One-year follow up of Fabry disease patients treated by IV administration of a plant derived alpha-Gal-A enzyme: safety and efficacy

Derralynn Hughes, Simeon Boyd, Pilar Giraldo, Derlis Gonzalez, Myrl Holida, Ozlem Goker-Alpan, Gustavo Maegawa, Mohamed Atta, Kathy Nicholls, Raphael Schiffmann, Ahmad Tuffaha, Laura Barisoni, Robert Colvin, J. Charles Jannette, Jenny Krupko, Mali Szlaifer, Einat Brill-Almon, Raul Chertkoff
  • Molecular Genetics and Metabolism, January 2017, Elsevier
  • DOI: 10.1016/j.ymgme.2016.11.158

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Mr Myrl D. Holida